Forum Markets, Inc. (FRMM)
4.90
+0.24
(+5.15%)
USD |
NASDAQ |
Sep 21, 16:00
4.90
0.00 (0.00%)
After-Hours: 20:00
Forum Markets Enterprise Value : 83.41M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 83.41M |
| September 17, 2026 | 85.19M |
| September 16, 2026 | 80.76M |
| September 15, 2026 | 81.69M |
| September 14, 2026 | 80.76M |
| September 11, 2026 | 82.22M |
| September 10, 2026 | 81.69M |
| September 09, 2026 | 82.88M |
| September 08, 2026 | 85.92M |
| September 04, 2026 | 91.99M |
| September 03, 2026 | 95.03M |
| September 02, 2026 | 94.90M |
| September 01, 2026 | 91.60M |
| August 31, 2026 | 96.75M |
| August 28, 2026 | 99.26M |
| August 27, 2026 | 96.62M |
| August 26, 2026 | 97.94M |
| August 25, 2026 | 99.59M |
| August 24, 2026 | 101.50M |
| August 21, 2026 | 94.24M |
| August 20, 2026 | 99.13M |
| August 19, 2026 | 99.26M |
| August 18, 2026 | 93.98M |
| August 17, 2026 | 99.66M |
| August 14, 2026 | 102.30M |
| Date | Value |
|---|---|
| August 13, 2026 | 104.28M |
| August 12, 2026 | 103.62M |
| August 11, 2026 | 104.41M |
| August 10, 2026 | 105.07M |
| August 07, 2026 | 101.37M |
| August 06, 2026 | 102.43M |
| August 05, 2026 | 104.15M |
| August 04, 2026 | 99.00M |
| August 03, 2026 | 91.20M |
| July 31, 2026 | 90.01M |
| July 30, 2026 | 92.79M |
| July 29, 2026 | 91.73M |
| July 28, 2026 | 92.13M |
| July 27, 2026 | 95.03M |
| July 24, 2026 | 97.54M |
| July 23, 2026 | 96.75M |
| July 22, 2026 | 97.15M |
| July 21, 2026 | 102.83M |
| July 20, 2026 | 101.90M |
| July 17, 2026 | 96.88M |
| July 16, 2026 | 99.06M |
| July 15, 2026 | 100.84M |
| July 14, 2026 | 111.68M |
| July 13, 2026 | 107.45M |
| July 10, 2026 | 100.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.815B |
| Alnylam Pharmaceuticals, Inc. | 31.72B |
| Anika Therapeutics, Inc. | 265.34M |
| Savara, Inc. | 960.37M |
| Vericel Corp. | 1.980B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.42M |
| Revenue (Quarterly) | 1.365M |
| Total Expenses (Quarterly) | 13.79M |
| EPS Diluted (Quarterly) | -0.7511 |
| Gross Profit Margin (Quarterly) | -39.41% |
| Profit Margin (Quarterly) | -910.0% |
| Earnings Yield | -677.2% |
| Normalized Earnings Yield | -477.97 |